Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
The market for analgesics in Indonesia is poised for continued healthy growth in current value terms in 2024, as these medications remain a popular choice for everyday health issues like fever and minor aches. A key factor driving the accessibility…
In 2024, Romania’s analgesics market is expected to maintain a robust performance in current value terms, with ibuprofen continuing to dominate sales. Renowned for its effectiveness in alleviating various types of pain - including arthritis,…
Analgesics in North Macedonia has performed well in 2024, with growth in total current value sales remaining robust and most categories expanding in retail volume terms. Buoyant demand continues to be underpinned by the fact that Macedonians are…
Analgesics continues to be a significant category in consumer health in Cameroon in 2024. Acetaminophen (paracetamol) in particular has become a staple product in households in the country, due to its versatility in dealing with headaches and fever,…
Analgesics are typically purchased without a prescription in Tunisia although they are exclusively sold in the pharmacy channel. Indeed, pharmacies state that over 80% of customers buy pain relief products without a prescription from a doctor. The…
Analgesics in Poland is expected to register healthy constant value growth. With the economy improving, there is expected to be less of a degree of trading down and this is expected to boost value growth. That being said, analgesics is a mature…
Although one of the fastest-growing landscapes for retail value sales, analgesics recorded a decline in retail volume sales in 2023, which is predicted for 2024. In 2021, around 100 million units of analgesics were sold in the OTC retail market;…
Analgesics remains the second biggest category in OTC in Ukraine and the third in consumer health overall in current value terms. Analgesics, which mostly carry an OTC status, including dipyrone, are popular for alleviating different types of pain,…
In 2024, analgesics are set to record positive retail value growth, while value growth is only set to be positive for topical analgesics/anaesthetic. Aligned with the health and wellness lifestyle trend, more people in Turkey are engaging in outdoor…
The market for analgesics in Taiwan is projected to continue growing in current value terms in 2024, with topical analgesics leading the way. These products present several advantages over oral pain relievers, including ease of use and the absence of…
Analgesics will continue to register a positive performance in current value terms in Switzerland in 2024, driven largely by a notable rise in respiratory illnesses. This resurgence is partly due to reduced immunity as a result of lower viral…
Analgesics is a key product area within consumer health in Sweden, accounting for over one-fifth of overall OTC value sales in 2024. The category witnessed moderate current value growth in 2024 as concerns regarding the economy abated and inflation…
Value sales of analgesics in South Africa continue to rise strongly in 2024, mainly driven by adult combination products for perceived higher effectiveness (benefiting leading brands such as Grand-Pa from GSK Consumer Healthcare and Adco-dol from…
The full return to normality following the COVID-19 pandemic results is driving further growth of analgesics in Slovenia in 2024. The category also received an additional boost due to rising prices as a result of lingering inflation. Several key…
Analgesics reported dynamic growth in constant value terms over 2024 due to further price increases. Consumption of adult analgesics has stabilised following a period of fluctuation over the review period, with sales peaking during the cold and flu…
Analgesics is expected to register double-digit current value growth in Pakistan in 2024, though constant value growth is expected to be muted, as inflation remains high. Acetaminophen continues to account for most value sales, with ibuprofen in…
In analgesics, manufacturers are employing various strategies to tackle inflationary pressures in Kenya and maintain retail value share. Beta Healthcare International has introduced Hedex Extra, a stronger yet affordable painkiller specifically…
Analgesics is set to record positive current value growth in Uruguay in 2024. Argentina’s exchange rate appreciated in the first quarter of 2024, which immediately impacted prices. Consequently, small-scale illicit trade decreased notably across the…
Demand for analgesics in Slovakia is expected to stabilise in 2024, following the sharp drop in retail volume across most subcategories in 2023. This contraction was driven in part by significant stockpiling of OTC analgesics at the end of…
Analgesics is set to see current value growth in Norway in 2024. The consumption of painkillers/analgesics is expected to increase during the year, following a corrective decline in 2023. The two previous years had seen booming growth, following the…